Journal club

Correspondence to Dr Fred Fyles, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; fred.fyles@doctors.org.uk Prophylactic antibiotics in idiopathic pulmonary fibrosis (IPF): best to avoid for now Lung dysbiosis is associated with disease progression in IPF. While the study has a number of limitations: low numbers in the MC≥0.95 GI/L cohort, higher rates of coronary artery disease among this group acting as a potential confounder, and lack of patients with severe IPF, the data are encouraging, suggesting further research into the prognostic value of MC is warranted. Measuring health-related quality of life (HRQL) in pulmonary fibrosis (PF): it only takes a minute (or 2) The importance of accurate assessment of HRQL is increasingly acknowledged in both research and clinical medicine.